Trade CGTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cognition Therapeutics, Inc. (CGTX) is trading at US$1.04, down 1.89% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$94.7M. Over the past 52 weeks, CGTX has traded between US$0.55 and US$2.05. On Syfe you can trade CGTX with $0 commission and add it to your watchlist.
| Previous close | US$1.06 |
|---|---|
| Market cap | US$94.7M |
| 52-week range | US$0.55 – US$2.05 |
| Volume | 336.21K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Year: 2021
Cognition Therapeutics Agrees With FDA on Phase 3 Trial Framework for Psychosis Treatment
Jun 24, 12:22 PM · MT Newswires
Cognition Therapeutics Receives Patent Allowance for Polymorphic Crystalline Form of Zervimesine
Jun 16, 12:19 PM · MT Newswires
Cognition Therapeutics, Inc. (CGTX) stock is trading at US$1.04, -1.89% from the previous close of US$1.06.
The market cap for Cognition Therapeutics, Inc. (CGTX) stock is approximately US$94.7M.
The 52-week high for Cognition Therapeutics, Inc. (CGTX) stock is US$2.05.
The 52-week low for Cognition Therapeutics, Inc. (CGTX) stock is US$0.55.
Cognition Therapeutics, Inc. (CGTX) does not currently pay a dividend.
Stay on top of CGTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
